Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts. - 26 Fun Urban areas For Seniors To Travel
- 3Finding Ideal Date Spots for Two or three Encounters
- 4Israel's Druze use AI to present to UN testimonies of 'sexual terrorism' against Syrian Druze women
- 5Astonishing interstellar comet captured in new images by NASA Mars missions
- The Most Rousing Ladies Business visionaries of Today
- Pat Finn, actor from 'The Middle,' dies at 60 after bladder cancer diagnosis
- The Ascent of Rousing Pioneers Who Formed History
- IDF kills senior PIJ Gaza City Brigade cmdr. who infiltrated Kibbutz Nahal Oz on Oct. 7
- Figure out How to Get a good deal on Your Rooftop Substitution Venture
- Looking for a great Thanksgiving side dish recipe? These are the crowd-pleasers the Yahoo team swears by.
- Doctors say changes to US vaccine recommendations are confusing parents and could harm kids
- Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
- Hundreds show fascist salute at rally in Rome in annual ritual
